| Product Code: ETC7355653 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Parkinsons Disease Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Parkinsons Disease Market - Industry Life Cycle |
3.4 Greece Parkinsons Disease Market - Porter's Five Forces |
3.5 Greece Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Greece Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Greece Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Greece Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Greece Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Greece Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing geriatric population in Greece |
4.2.2 Growing awareness about Parkinson's disease among healthcare professionals and patients |
4.2.3 Advancements in medical technology and treatment options for Parkinson's disease |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in certain regions of Greece |
4.3.2 High cost associated with Parkinson's disease treatment and medications |
4.3.3 Lack of comprehensive government support and funding for Parkinson's disease management |
5 Greece Parkinsons Disease Market Trends |
6 Greece Parkinsons Disease Market, By Types |
6.1 Greece Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Greece Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Greece Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Greece Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Greece Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Greece Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Greece Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Greece Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Greece Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Greece Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Greece Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Greece Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Greece Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Greece Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Greece Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Greece Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Greece Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Greece Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Greece Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Greece Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Greece Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Greece Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Greece Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Greece Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Greece Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Greece Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Greece Parkinsons Disease Market Export to Major Countries |
7.2 Greece Parkinsons Disease Market Imports from Major Countries |
8 Greece Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis for Parkinson's disease patients in Greece |
8.2 Number of neurologists specializing in movement disorders in Greece |
8.3 Percentage of Parkinson's disease patients in Greece receiving multidisciplinary care and support |
8.4 Adoption rate of emerging therapies and technologies in Parkinson's disease management in Greece |
9 Greece Parkinsons Disease Market - Opportunity Assessment |
9.1 Greece Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Greece Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Greece Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Greece Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Greece Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Greece Parkinsons Disease Market - Competitive Landscape |
10.1 Greece Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Greece Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here